自杀捐赠者与心脏移植结果之间的关联:回顾性队列研究
Álvaro Perazzo1,2,3,4, Samuel Padovani Steffen1,2, Aichah Ahmad El Orra5
1Transplant Center, Instituto do Coração (InCor), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HC-FMUSP), São Paulo, São Paulo, Brazil.
Brazilian journal of cardiovascular surgery
|July 24, 2025
概括
使用自杀捐赠者的器官进行心脏移植与更糟糕的结果有关. 接受者面临更高的初级移植功能障碍和早期死亡率,这表明需要进一步调查捐赠者选择.
科学领域:
- 心脏病学 心脏病学
- 移植手术 移植手术
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 在心脏移植中使用自杀捐赠者的器官存在道德和临床挑战.
- 人们担心,自杀捐赠者的心脏移植后,移植功能和接受者的存活率存在问题.
研究的目的:
- 调查使用自杀捐赠者的心脏移植与原发性移植功能障碍 (PGD) 的发生率之间的联系.
- 评估自杀性供体心脏移植对30天死亡率的影响.
主要方法:
- 对97名心脏移植患者进行了回顾性分析.
- 数据包括供体和受体特征,手术内变量和术后结果.
- 统计分析比较了自杀和非自杀捐赠群体之间的结果.
主要成果:
- 六次移植 (6.2%) 使用来自自杀捐赠者的心脏.
- 自杀的捐赠者使用ECMO (33.3%对比4.4%),PGD (66.7%对比19.8%) 和30天死亡率 (50%对比3.3%) 的比例显著更高.
- 没有观察到手术内时间的显著差异.
结论:
- 这项研究是第一个证明自杀捐赠者的心脏移植与不良结果之间存在显著联系的研究.
- 在接受自杀性捐赠心脏的人群中观察到更高的PGD和早期死亡率.
- 需要进一步的研究,以了解对器官质量的生物学和心理影响,并完善供体选择标准.
相关概念视频
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:24Tissue Transplantation
521
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
521
01:22Bone Marrow Sampling and Transplants
502
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502